Featured Products
Read More
Coronavirus Libraries
new
To contribute to multi-task and interdisciplinary efforts to overcome COVID-19 pandemic, Life Chemicals has designed three original Coronavirus Screening Libraries intended for the development of innovative and specific antiviral therapeutics towards COVID-19. The selected drug-like screening compounds possess predicted activity against SARS-CoV-2.
Read More
Antiviral Screening Libraries
updated
Antiviral Libraries were designed with 2D similarity or a combination of ligand-based structure-based approaches and aim high throughput screening (HTS) and high content screening (HCS) projects. Over 13,700 drug-like screening compounds with potential antiviral activity against various virus species and antiviral molecular targets were selected.
Read More
RNA Focused Library
updated
Life Chemicals has developed its RNA Screening Library of over 3,300 drug-like compounds with predicted RNA-binding activity as an excellent starting point for post-transcriptional gene regulation, antibacterial, and antiviral drug discovery research. It has been designed with two ligand-based approaches: 2D Similarity Search and Bayesian Modeling.
Read More
Pre-plated Diversity Sets
updated
Exclusive non-overlapping Pre-plated Diversity Sets are composed of 5,000, 10,000, 15,000, and 20,000 screening compounds (in total, 50,000 novel structurally-diverse molecules) with optimal physico-chemical properties, selected by dissimilarity search with the average Tanimoto threshold of 80%. They are ideal starting kit for phenotypic and target-based HTS.
Read More
STING Targeted Library
new
The new STING Targeted Library comprises potential agonists of the cellular double-stranded DNA sensor STING. It was created by docking-based virtual screening, resulting in 1,600 drug-like compounds (Ro5-compliant, reactive and toxic groups removed). The docking score value is available for each compound in the compound structure file provided on requests.
Read More
ALK Tyrosine Kinase Focused Library
new
Anaplastic lymphoma kinase (ALK) is a member of the family of insulin-like tyrosine kinase receptors involved in the oncogenesis of several tumor types. 2,500 potential ALK inhibitors were selected by the ligand-based approach. The Life Chemicals HTS Compound Collection was searched for structural analogs of the compounds from the reference set, using several 2D similarity methods.